PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS IN THE 21st CENTURY: FOCUS ON RITUXIMAB
Rheumatoid arthritis (RA) is one of the most common and severe chronic inflammatory diseases. The paper reviews the recent studies evaluating the efficacy of rituximab (MabThera®), chimeric anti-CD20 monoclonal antibodies in B cells, in patients with RA. It has been shown that Rituximab is an extrem...
| Главный автор: | |
|---|---|
| Формат: | Статья |
| Язык: | Russian |
| Опубликовано: |
IMA-PRESS LLC
2009-12-01
|
| Серии: | Современная ревматология |
| Предметы: | |
| Online-ссылка: | https://mrj.ima-press.net/mrj/article/view/261 |